Stock-Based Compensation - Additional information (Details) - USD ($) $ / shares in Units, $ in Millions |
9 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Stock-Based Compensation | ||
| Stock-based compensation includes reversal of expense | $ 0.4 | |
| Unrecognized compensation costs | $ 0.6 | |
| Weighted-average amortization period | 3 years 7 months 13 days | |
| Intrinsic value of stock options exercised | $ 0.3 | $ 0.3 |
| Weighted average grant date fair value of options granted | $ 3.21 | $ 23.31 |
| 2016 Plan | ||
| Stock-Based Compensation | ||
| Number of common stock authorized | 14,584 | |
| Common shares were available for future grants | 13,334 | |
| 2019 Plan | ||
| Stock-Based Compensation | ||
| Number of common stock authorized | 366,924 | |
| Common shares were available for future grants | 155,994 | |
| X | ||||||||||
- Definition Amount of stock-based compensation expense reversed during the period that was previously recognized. No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|